As per the report published by Allied Market Research, the global blood stream infection testing market would reach $5.17 billion by 2021, and would generate $10.54 billion by 2030, growing at a CAGR of 8.3% from 2022 to 2030. The report provides an in-depth analysis of top segments, changing market trends, value chain, key investment pockets, competitive scenario, and regional landscape. The report is an essential and helpful source of information for leading market players, investors, new entrants, and stakeholders in formulating new strategies for the future and taking steps to strengthen their position in the market.
Blood stream infection is a condition where any bacterial, fungal or any type of infection is detected in the blood. The condition is evident when the infection enters into the blood stream of any part of the body. The bacteria or organisms that causes the blood infection are determined by using blood stream infection testing. Increasing incidences of bloodstream infection in elderly population who are susceptible to infection due to low immunity is anticipated to drive the global bloodstream infection testing market demand and boost revenue growth of the market. The initiatives of various organizations to spread awareness regarding transfusion-transmitted infections is also expected to boost the market growth. High demand for technologically advanced diagnostic tests, awareness about hygiene, diagnosis rate, and unhealthy lifestyle are also expected to fuel the market growth over the forecast period.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/3934
However, absence of proper healthcare facilities related to medical testing, high diagnosis cost, and stringent regulatory situation acts as a hindrance to revenue growth of the market. The introduction of new cost-efficient and easy to use devices are projected to generate new opportunities for the major players within the forecast period.
Blood Stream Infection Testing Market Segmentation
Based on technology, the culture-based segment dominated the market in terms of revenue in 2021, contributing to around three-fifths of the market. However, the molecular segment is expected to manifest the highest CAGR of 9.2% during the forecast period.
On the basis of product, the instruments segment is estimated to register the highest CAGR of 8.7% during the forecast period. However, the consumables segment held the lion’s share in 2021, accounting for nearly four-fifths of the market.
Based on technique, the automated segment is projected to register the highest CAGR of 9.1% during the forecast period. However, the conventional segment held the largest share in 2021, accounting for more than two-thirds of the market.
On the basis of application, the bacterial segment held the largest share in 2021, contributing to more than half of the market. In addition, the segment is projected to register the highest CAGR of 8.9% during the forecast period.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/3934
Based on end-users, the independent diagnostics centers segment is estimated to showcase the highest CAGR of 8.8% during the forecast period. However, the hospitals segment held the largest share in 2021, accounting for more than half of the market.
The global blood stream infection testing market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Asia-Pacific is projected to portray the highest CAGR of 9.2% during the forecast period. However, the market across North America would contribute the largest share in 2021, accounting for around two-fifths of the market.
Major Market Players
The global blood stream infection testing market includes an in-depth analysis of the prime market players such as Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Abbott, BD, BIOMÉRIEUX, Cepheid, Luminex Corporation, Accelerate Diagnostics Inc., AdvanDX, and Bruker.
The report analyzes these key players in the global blood stream infection testing market. These players have adopted various strategies such as new product launches, expansion, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments of every market player.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the market analysis from 2021 to 2031 to identify the prevailing blood stream infection testing market Opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the market segmentation assists to determine the prevailing blood stream infection testing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global blood stream infection testing market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the blood stream infection testing market players.
- The report includes the analysis of the regional as well as global trends, key players, market segments, application areas, and market growth strategies.
Read More:
Operating Room Management Market Worth USD 10.0 billion by 2031 at a CAGR of 13.0%
Hemodialysis Market to Reach US$ 111.8 Billion in 2032, Says Allied Market Research
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
